Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Gains 4%; BSE HEALTHCARE Index Up 1.2%
Wed, 7 Aug 9:58

Lupin Gains 4%; BSE HEALTHCARE Index Up 1.2%Image source: phive2015/www.istockphoto.com

Lupin share price has zoomed 4% and is presently trading at Rs 1,986.8.

Meanwhile, the BSE HEALTHCARE index is at 40,493.5 (up 1.2%).

Among the top gainers in the BSE HEALTHCARE index today are AJANTA PHARMA (up 4.3%) and Natco Pharma (up 4.3%).

GLAND PHARMA (down 3.1%) and Jubilant Pharmova (down 1.4%) are among the top losers today.

Over the last one year, Lupin has moved up from Rs 1,081.4 to Rs 1,986.8, registering a gain of Rs 905.4 (up 83.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 40,493.5, registering a gain of 43.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 113.2%), GRANULES INDIA (up 105.6%) and GSK Pharma (up 104.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,232.0 (up 0.8%).

The top gainers among the BSE Sensex today are M&M (up 2.1%) and MUNDRA PORT & SEZ (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,216.1 (up 0.9%). ONGC and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,232.0, registering a gain of 13,278.5 points (up 20.1%).

Lupin Financial Update...

Lupin net profit grew 77.7% YoY to Rs 8,055 million for the quarter ended June 2024, compared to a profit of Rs 4,533 million a year ago. Net sales rose 16.3% to Rs 56,003 million during the period as against Rs 48,141 million in April-June 2023.

For the year ended March 2024, Lupin reported 332.3% increase in net profit to Rs 19,356 million compared to net profit of Rs 4,477 million during FY23. Revenue of the company grew 20.2% to Rs 200,108 million during FY24.

The current Price to earnings ratio of Lupin, based on rolling 12 month earnings, stands at 39.6.


Equitymaster requests your view! Post a comment on "Lupin Gains 4%; BSE HEALTHCARE Index Up 1.2%". Click here!